Feed APYX
AP

Apyx Medical Corporation APYX NASDAQ · Healthcare · United States

$2.40 +0.42% +$0.01

Market cap
$100.7M
Enterprise value
$114.6M
P/E
-
Forward P/E
-
PEG
-
P/S
1.7x
P/FCF
-
EV/EBITDA
-
ROIC
-6.8%
Gross margin
34.5%
Net margin
-14.2%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
1.31
Free float
86.4%

About the company

Apyx Medical Corporation (APYX) is a company focused on the development and manufacturing of medical devices and technologies for aesthetic surgery and dermatology. Their main product is the J-Plasma® system, which combines radiofrequency energy with inert argon to create cold plasma for surgical procedures with minimal damage to surrounding tissues. This technology is utilized for various aesthetic procedures, including wrinkle removal, liposuction, skin rejuvenation, and more. Apyx Medical Corporation also focuses on developing and innovating in the field of dermatological and aesthetic medical devices to provide advanced solutions for physicians and their patients. Shares of Apyx Medical Corporation (APYX) could be suitable for investors who are tracking the healthcare sector and seeking investment opportunities in aesthetic surgery and dermatology.

Sector

Healthcare

Industry

Medical - Specialties

CEO

Charles D. Goodwin

Employees

205

Headquarters

Clearwater

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
  • What to watch: Revenue growth is slowing: 5.9% a year over the last 3 years against 14% over 5 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy